Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2019 / Jul / A Meaningful Microbiome
Microbiology & Immunology Microbiology and Immunology Oncology Cytology Infectious Disease

A Meaningful Microbiome

Cervical microbiota could help diagnosticians spot patients at high risk of cancer

By Michael Schubert 07/05/2019 Quick Read (pre 2022) 1 min read

Share

The gut microbiome is increasingly well known for its diagnostic potential and its effect on overall health. But just because it’s the most famous doesn’t mean it’s the only one; a new study has revealed the potential of the cervical microbiome as a biomarker of cervical cancer risk.

A transatlantic group of researchers from the University of Nebraska–Lincoln and Tanzania’s Ocean Road Cancer Institute conducted a study to investigate the relationship between human papillomavirus (HPV), human immunodeficiency virus (HIV), and cervical dysplasia (1). To that end, they collected cytobrush samples from the cervical lesions of 144 Tanzanian women and performed 16S rRNA gene deep sequencing to examine the microbiota present. The goal? To understand how the bacterial community differs between patients with different HIV status and cytology grade.

The researchers discovered that HIV significantly increases the overall richness of the cervical microbiome. HIV-positive individuals showed higher rates of Bacillus and Mycoplasma species, but lower rates of Lactobacillus species in particular.

Additionally, different grades of precancerous lesion were associated with different microbiota after separating HIV-positive and HIV-negative groups. Bacteria of the Mycoplasmatales order increased in abundance as lesion severity increased, from 0.2 percent of the total microbiome in the absence of lesions to 3.9 percent in high-grade squamous intraepithelial lesions. The higher-grade lesions also showed increased overall microbial diversity. “There are certain families of bacteria that appear to be associated with the higher grades of precancerous lesions,” said lead author Peter Angeletti in a recent press release (2).

It’s possible that, one day, analysis of the cervical microbiome could help diagnosticians better spot patients at risk of cervical cancer – the second-most common cancer in women living in underdeveloped areas, and the fourth-most common in women worldwide. The study’s authors are optimistic that, one day, such analysis might even allow for the development of preventative treatments that modulate the cervical microbiome for better health.

Caption: Lead author Peter Angeletti and first author Cameron Klein. Credit: Craig Chandler | University Communication.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. C Klein et al., “Relationship between the cervical microbiome, HIV status, and precancerous lesions”, MBio, 10, e02785018 (2019). PMID: 30782659.
  2. L Reed, “Link between cervical microbiome and cancer discovered” (2019). Available at: https://bit.ly/2SO5yBW. Accessed June 7, 2019.

About the Author(s)

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

More Articles by Michael Schubert

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Context Matters in Cancer Biology
Microbiology and Immunology
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

What’s New in Infectious Disease? (December 2021)
Microbiology and Immunology
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Microbiology and Immunology
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

2021: A Laboratory Medicine Roundup
Microbiology and Immunology
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.